POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al
Case Number:
3:15-cv-07658
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Robinson Miller
- Bandas Law Firm
- Kelley Drye
- Calcagni & Kanefsky
- HGT Law
- Skoloff & Wolfe
- Brodsky Smith
- McDermott Will & Schulte
- Hartmann Doherty
- Kroll Heineman
- Whipple Azzarello
- McElroy Deutsch
- McKenney & Froelich
- Winston Taylor
- Kessler Topaz
- FBT Gibbons
- Trief & Olk
- Carella Byrne
- Safirstein Law
- Seeger Weiss
- Hach Rose Schirripa
- Cohn Lifland
- Cleary Gottlieb
- Patunas Law
- Midlige Richter
- Fisher & Phillips
- O'Melveny & Myers
- Fleischman Bonner
- Cohen Milstein
- Debevoise & Plimpton
- Greenberg Traurig
- Entwistle & Cappucci
- Lowenstein Sandler
- Cole Schotz
- Kasowitz LLP
- Critchley Kinum
- McCarter & English
- Bressler Amery
- Mintz Levin
- Chiesa Shahinian
- Lite DePalma
- Kirby McInerney
- Rolnick Kramer
- Frier Levitt
- Kranjac Tripodi
Companies
- Janus Henderson Group PLC
- BMO Capital Markets Corp.
- Transatlantic Reinsurance Co.
- United Services Automobile Association
- RBC Capital Markets
- Pacific Compensation Insurance Co.
- Teachers Insurance & Annuity Association of America
- DBS Group Holdings
- Lord Abbett & Co. LLC
- Minnesota Life Insurance Co.
- The Goldman Sachs Group Inc.
- Two Sigma Investments LP
- Conagra Brands Inc.
- Massachusetts Mutual Life Insurance Co.
- TD Securities Inc.
- Bausch Health Cos. Inc.
- JPMorgan Chase & Co.
- GIC Private Ltd.
- The Northwestern Mutual Life Insurance Co.
- ValueAct Capital Management LP
- T. Rowe Price Group Inc.
- CapSpecialty Inc.
- Alleghany Corp.
- Multi-Color Corp.
- SIFMA
- AIG Retirement Services Co.
- The Boeing Co.
- Barclays PLC
- Securian Financial Group Inc.
- DNB ASA
- Obsidian
- Deutsche Bank AG
- Citigroup Inc.
- Bank of America Corp.
- BlackRock Inc.
- PricewaterhouseCoopers LLP
- Morgan Stanley
- HSBC Holdings PLC
Government Agencies
Sectors & Industries:
-
October 23, 2015
Valeant Hit With Investor Suit Over Pharmacy Ties
Valeant Pharmaceuticals International Inc. fraudulently concealed questionable relationships with specialty pharmacies and is liable for steep losses that shareholders suffered after the relationships came to light, according to a proposed securities class action filed Thursday in New Jersey federal court.
- ← Previous
- 1
- 2
- 3
- Next →